Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1021 |
---|---|
Product Name | Anti-Human CD22 Recombinant Antibody(Epratuzumab) |
Molecular Name | Epratuzumab |
Alias | Anti-CD22 Recombinant Antibody, Research Grade Epratuzumab |
CAS Number | 205923-57-5 |
Target | CD22[Homo sapiens] |
Isotype | IgG1 |
Clonity | Monoclonal |
Host | Mouse |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | IF, IP, Neut, FuncS, ELISA, FCM, ICC, Activ, WB |
Buffer | PBS, pH7.5 |
Background | Epratuzumab (planned trade name LymphoCide) is a humanized monoclonal antibody. Potential uses may be found in oncology and in treatment of inflammatory autoimmune disorders, such as systemic lupus erythematosus (SLE). |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |